Search

Presentations

EHA-TSH Hematology Tutorial on T Cell LymphomasSession 1: New classification and epidemiology of T cell diseases

Lecture: V Tabanelli (here)
Session 2: How I treat PTCL NOS patients

Lecture: E Birtaş Ateşoğlu (here)
Clinical Case: E Kırcalı (here)
Self-assessment Case: E Birtaş Ateşoğlu (here)
Session 3: First line treatment of…

Read more

Abstract Presentation Information

Thank you for submitting your abstract to the EHA-SfPM Precision Medicine Meeting, to be held on September 25-27, 2024 in Copenhagen, Denmark.

Read more

Presentations

EHA-GBMTA-AHA Hematology Tutorial

Session 1: Indolent Non-Hodgkin Lymphoma

Lecture: M Gomes da Silva 
Clinical Case: M Kurtsadze 
Self-assessment Cases: M Gomes da Silva 
Session 2: Aggressive Non-Hodgkin Lymphoma

Lecture: K Polgárová
Clinical Case: G Saghumyan
Self-assessment Cases: K Polgárová
Session 3: Myeloproliferative neoplasms (MPN)

Lecture: P Harrington
Clinical Case: K Meliksetyan
Self-assessment Cases: P Harrington
Session 4: Hodgkin Disease

Lecture: I Aurer
Clinical Case: M Zarandia 
Self-assessment…

Read more

Promising results in trials with non-chemotherapy treatments for Leukemias to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013

What is new? Current investigations are aimed at evaluating the use of monoclonal antibodies (mAB). These mABs bind to specific molecules (antigens) found on leukemic cells. This results in immune destruction of the leukemic cells.

Read more

Press release: Work of 2013 Nobel Prize in Physiology or Medicine winners to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013

With the Scientific Working Group for Stem Cells, the 18th Congress of EHA took the opportunity to acknowledge the work of the 2013 winner of the Nobel Prize for Medicine or Physiology, Drs John B.

Read more

Selected EMA news

October 2024New medicines recommended for approval
Pomalidomide Teva (pomalidomide) – generic
Treatment of multiple myeloma (a type of blood cancer)

Hympavzi (marstacimab) – orphan medicine
Treatment of bleeding episodes
New information on approved medicines
Darzalex (daratumumab) – new indication – orphan medicine
Treatment of multiple myeloma (a…

Read more

Stem Cells

Mission:

The goal of the SWG on Stem Cells is to bring together researchers, biologists and clinicians involved in stem cell research to share their recent advances in the field, as well as to train new junior members.

Read more

Registration & accommodation

Registration is closed. The EHA-EBMT 6th European CAR T-cell Meeting provides opportunities for students, trainees, nurses and others to join the meeting for a discounted fee.

Read more

Pediatric Hematology

The SWG on Pediatric Hematology has several key goals for the next four years (2024–2026):

To further develop our role as the voice of pediatric hematology within EHA
To reach out to YEHA pediatric hematologists to develop educational material to underpin our…

Read more